Merck, a prominent science and technology company, has entered into a Memorandum of Understanding (MOU) with ChemLex, an innovation-driven firm based in Singapore. This...
A large-scale study has revealed that the shingles vaccine, Zostavax, developed by Merck, significantly reduces the risk of death from dementia among older adults....
UPDATE: A groundbreaking study has revealed that Merck’s Zostavax shingles vaccine significantly reduces the risk of death from dementia. Researchers in Wales found that...
UPDATE: Australian shares are poised to open higher today, October 24, 2023, following a strong performance from the Dow, which gained momentum on news...